THE NIFTY™ TEST
The World’s Leading Non-Invasive Prenatal Test (NIPT). Over 10 MILLION Samples Processed To Date.
THE NIFTY™ TEST
The World’s Leading Non-Invasive Prenatal Test (NIPT). Over 3 MILLION Samples Processed To Date.
SERVICES
ONCOLOGY
BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.
REPRODUCTIVE HEALTH
VISTA™ Carrier Screening detects 15,000 mutations across 547 genes, for 626 autosomal-recessive and X-linked genetic disorders.
VISTA™ PGS is used in conjunction with an IVF cycle. Embryos remain on-site at the patient’s IVF center. Cells are removed from an embryo and sent to BGI for genetic analysis.
NEWBORN SCREENING
Each year, an estimated 7.9 million babies worldwide are born with birth defects, Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.
CLINICAL EXOME SEQUENCING
BGI’s Whole Clinical Exome Sequencing examines the DNA sequence of over 180,000 exons across 22,000 genes, screening for more than 5,800 monogenic diseases.
BGI LOCAL LABORATORY SOLUTION
BGI is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge.
Genetic disease raises many questions. We’re empowering healthcare providers with the information
they need to answer these questions, in order to both prevent disease and better guide patient treatment
decisions.
BGI acts as one of the world’s most tried and trusted clinical genomic partners with experience
in diagnostic and screening tests. We have a worldwide network of offices and laboratories.
BGI LOCAL LABORATORY SOLUTION
BGI is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge.
Genetic disease raises many questions. We’re empowering healthcare providers with the information they need to answer these questions, in order to both prevent disease and better guide patient treatment decisions.
BGI acts as one of the world’s most tried and trusted clinical genomic partners with experience in diagnostic and screening tests. We have a worldwide network of offices and laboratories.
